Published in J Rheumatol on July 01, 1990
Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest (1994) 1.23
Antiphospholipid antibodies predict progression of abdominal aortic aneurysms. PLoS One (2014) 0.76
Antineutrophil cytoplasmic antibodies in giant cell arteritis. J Rheumatol (1991) 0.75
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Optokinetic therapy improves text reading in patients with hemianopic alexia: a controlled trial. Neurology (2007) 2.91
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem (1996) 2.33
Management of acute optic neuritis. Lancet (2002) 2.33
Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res (1995) 2.01
Epilepsy surgery, visual fields, and driving: a study of the visual field criteria for driving in patients after temporal lobe epilepsy surgery with a comparison of Goldmann and Esterman perimetry. J Neurol Neurosurg Psychiatry (2000) 1.77
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res (2001) 1.76
Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis. Arch Biochem Biophys (2000) 1.73
The functional anatomy of single-word reading in patients with hemianopic and pure alexia. Brain (2001) 1.66
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res (1997) 1.63
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond) (2013) 1.61
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry (2005) 1.59
Optic neuritis: a review. Int MS J (2009) 1.55
A 'web app' for diagnosing hemianopia. J Neurol Neurosurg Psychiatry (2012) 1.53
[Treatment of optic neuritis]. Ned Tijdschr Geneeskd (2004) 1.39
Brain biopsy in dementia. Brain (2005) 1.36
A hypothetical scheme for the brainstem control of vertical gaze. Neurology (2000) 1.36
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest (2000) 1.34
Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry (2010) 1.30
Serial magnetization transfer imaging in acute optic neuritis. Brain (2004) 1.24
A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol (2010) 1.20
Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations. Br J Ophthalmol (2004) 1.19
Functional magnetic resonance imaging of the cerebral response to visual stimulation in medically unexplained visual loss. Psychol Med (2004) 1.19
Optic neuritis following measles/rubella vaccination in two 13-year-old children. Br J Ophthalmol (1996) 1.15
Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology (2000) 1.14
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem (1999) 1.14
Familial neuromyelitis optica. Neurology (2010) 1.14
Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci U S A (1997) 1.10
Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry (2000) 1.10
Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Neurosurg Psychiatry (2001) 1.09
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain (2004) 1.09
Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry (2003) 1.08
Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain (2001) 1.06
Optic neuritis. Eye (Lond) (2011) 1.05
Metastatic choriocarcinoma presenting as multiple intracerebral haemorrhages: the role of imaging in the elucidation of the pathology. J Neurol Neurosurg Psychiatry (1998) 1.04
Structural anatomy of pure and hemianopic alexia. J Neurol Neurosurg Psychiatry (2006) 1.03
Relapsing intracranial Rosai-Dorfman disease. J Neurol Neurosurg Psychiatry (2001) 1.03
Axonal degeneration and inflammation in acute optic neuritis. J Neurol Neurosurg Psychiatry (2004) 1.02
The variants of reading epilepsy. A clinical and video-EEG study of 17 patients with reading-induced seizures. Brain (1998) 1.02
Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease. Clin Exp Immunol (1988) 1.01
Behçet's disease with slowly enlarging midbrain mass on MRI: resolution following steroid therapy. Neurology (1989) 1.00
The pattern evoked electroretinogram in optic neuritis. A combined psychophysical and electrophysiological study. Brain (1986) 1.00
Colour and luminance vision in human optic neuritis. Brain (1986) 0.99
The effect of temporal frequency variation on threshold contrast sensitivity deficits in optic neuritis. J Neurol Neurosurg Psychiatry (1983) 0.99
Frequency and characteristics of visual field deficits after surgery for mesial temporal sclerosis. Neurology (1993) 0.99
Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology (2001) 0.98
Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry (2001) 0.97
A work out for hemianopia. Br J Ophthalmol (2005) 0.97
Ocular neuromyotonia. Br J Ophthalmol (1996) 0.96
Biosynthesis and processing of cathepsin K in cultured human osteoclasts. Bone (2001) 0.96
Insights into the different exploits of colour in the visual cortex. Proc Biol Sci (1994) 0.96
Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry (2002) 0.96
Optic disc duplication or coloboma? Br J Ophthalmol (2005) 0.96
A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychiatry (2001) 0.96
CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol (2000) 0.95
Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis. Mult Scler (2007) 0.95
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J Bone Miner Res (2001) 0.94
The optic nerve sheath on MRI in acute optic neuritis. Neuroradiology (2005) 0.94
Nasal field loss in kittens reared with convergent squint: neurophysiological and morphological studies of the lateral geniculate nucleus. J Physiol (1977) 0.94
Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain (2005) 0.93
Myxoedema presenting with chiasmal compression: resolution after thyroxine replacement. Lancet (1987) 0.93
Ladies with Leber's hereditary optic neuropathy: an atypical disease. Eur J Ophthalmol (2003) 0.93
MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry (2010) 0.92
Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology (2002) 0.91
Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology (1999) 0.90
Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice. Matrix Biol (2005) 0.90
Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. Mult Scler (2010) 0.90
Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J Neurol Neurosurg Psychiatry (2001) 0.89
Steroid-responsive HIV optic neuropathy. J Neuroophthalmol (1998) 0.89
CNTO 530: molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in mice. J Biotechnol (2007) 0.88
Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry (2009) 0.88
Asymmetrical activation of human visual cortex demonstrated by functional MRI with monocular stimulation. Neuroimage (2001) 0.88
Central and paracentral visual field defects and driving abilities. Ophthalmologica (2005) 0.88
Functional magnetic resonance imaging of the cortical response to photic stimulation in humans following optic neuritis recovery. Neurosci Lett (2002) 0.88
Temporal frequency discrimination in optic neuritis and multiple sclerosis. Brain (1985) 0.88
Transient visually evoked potentials to the pattern reversal and onset of sinusoidal gratings. Electroencephalogr Clin Neurophysiol (1983) 0.88
Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials. J Neurol (1999) 0.88
Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis. Clin Exp Immunol (1990) 0.87
Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci (1999) 0.87
The fortification spectra of migraine. Br Med J (Clin Res Ed) (1987) 0.87
Quantification of optic nerve head topography in optic neuritis: a pilot study. Br J Ophthalmol (2006) 0.86
Ataxia in the setting of complicated enteropathy: double jeopardy. J Neurol Neurosurg Psychiatry (2002) 0.86
Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation. Acta Neuropathol (1999) 0.86
Early MRI in optic neuritis: the risk for disability. Neurology (2009) 0.86
Recurrent ptosis. J Neurol Neurosurg Psychiatry (2001) 0.86
An epidemic of optic neuropathy and painful sensory neuropathy in Cuba: clinical aspects. J Neurol (1995) 0.86
Tuberculous orbital apex syndromes. Br J Ophthalmol (2008) 0.86
Ultrastructural quantification of cell death after injurious compression of bovine calf articular cartilage. Osteoarthritis Cartilage (2004) 0.86
Visual evoked potentials in konzo, a spastic paraparesis of acute onset in Africa. Ophthalmologica (2003) 0.86
B Cell lymphoma of the brain stem masquerading as myasthenia. J Neurol Neurosurg Psychiatry (2002) 0.85
Nemaline myopathy: an unusual cause of ophthalmoparesis. J Neuroophthalmol (1997) 0.85
Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. J Med Chem (2000) 0.84
Ataxia telangiectasia: a reappraisal of the ocular motor features and their value in the diagnosis of atypical cases. Mov Disord (1989) 0.84
Ventricular enlargement in MS: one-year change at various stages of disease. Neurology (2006) 0.84
Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison. J Neurol Neurosurg Psychiatry (2006) 0.83
Familial paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry (1984) 0.83
Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein. J Neurol Sci (1995) 0.83